Previous 10 | Next 10 |
Volt Information Sciences (NYSE:VOLT) +96% on acquisition proposal from ACS Solutions affiliate. Zhongchao (NASDAQ:ZCMD) +41%. Turquoise Hill Resources (NYSE:TRQ) +31% after receiving Rio Tinto's takeover proposal. Amphastar Pharmaceuticals (NASDAQ:AMPH) +24%. Mullen Autom...
Worries that a drawn-out conflict in Ukraine would significantly dent the global economy led to another day of selling on Friday. The major averages slumped again, led by a 2.2% drop in the Nasdaq. The S&P 500 fell 1.3% and once again came within striking distance of 4,200. Software-as-a-...
The shares of the generic drugmaker, Amphastar Pharmaceuticals (AMPH +11.3%), have recorded the sharpest intraday gain in nearly two years on Friday as investors react to the company’s better-than-expected financials for Q4 2021. Citing the company’s unique position among its pe...
Image source: The Motley Fool. Amphastar Pharmaceuticals (NASDAQ: AMPH) Q4 2021 Earnings Call Mar 10, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Amphastar Pharmaceuticals (AMPH) Q4 2021 Earnings Call Transcript...
Amphastar Pharmaceuticals, Inc. (AMPH) Q4 2021 Earnings Conference Call March 10, 2022 05:00 PM ET Company Participants Dan Dischner - VP, Corporate Communications Bill Peters - CFO Tony Marrs - SVP, Regulatory Affairs and Clinical Operations Conference Call Participants David Amsellem - Pipe...
The following slide deck was published by Amphastar Pharmaceuticals, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Amphastar Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call Presentation
Amphastar Pharmaceuticals press release (NASDAQ:AMPH): Q4 Non-GAAP EPS of $0.42 beats by $0.05. Revenue of $120.9M (+26.0% Y/Y) beats by $9.28M. For further details see: Amphastar Pharmaceuticals Non-GAAP EPS of $0.42 beats by $0.05, revenue of $120.9M beats by $9.28M
Reports Net Revenues of $120.9 Million for the Three Months Ended December 31, 2021 RANCHO CUCAMONGA, CA / ACCESSWIRE / March 10, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months and full-year ended December ...
The shares of Viatris (NASDAQ:VTRS) and Teva (VTRS) have well underperformed the broader market over the past 12 months. Weighed down by pricing pressure and opioid-related liabilities, Teva (NYSE:TEVA) has lost ~25%, while high leverage and, most recently, the decision to divest biosimilar a...
RANCHO CUCAMONGA, CA / ACCESSWIRE / March 3, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its fourth quarter of 2021 ended December 31, 2021, after the market closes on Thursday, March 10 th , 2022, and will hold a conference call t...
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Complete Solaria Inc Com (CSLR) rose 58.5% to $1.775 on volume of 71,457,263 shares Senti Biosciences Inc. (SNTI) rose 55.1% to $0.428 on volume of 64,207,396 shares Golden Heaven Group Holdings Ltd. (GDHG) rose 13.3% to $0.1711 on vo...
2024-06-19 18:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...